Status:
NOT_YET_RECRUITING
Study of Metabolic Dysfunction-Associated Steatotic Liver Disease Among Sohag University Employees
Lead Sponsor:
Sohag University
Conditions:
Metabolic Dysfunction-Associated Steatotic Liver Disease
Eligibility:
All Genders
18-60 years
Brief Summary
* Metabolic dysfunction-associated steatotic liver disease (MASLD) is the latest term for steatotic liver disease associated with metabolic syndrome. MASLD is a common cause of chronic liver disease a...
Eligibility Criteria
Inclusion
- 100 Employees in Sohag University will be included in the study.
Exclusion
- Employees with drug induced liver disease. Employees with chronic liver disease. Employees with decompensated liver cirrhosis. Employees with excessive alcohol consumption.
Key Trial Info
Start Date :
September 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06536933
Start Date
September 1 2024
End Date
December 31 2024
Last Update
August 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sohag university Hospital
Sohag, Egypt